|Bid||0.045 x 0|
|Ask||0.050 x 0|
|Day's Range||0.045 - 0.045|
|52 Week Range||0.045 - 0.120|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
As part of the previously announced strategic review process that is being overseen by a special committee of independent directors of the Company, steps have been implemented to reduce staffing levels at the Company’s subsidiary companies, Xenemetrix, Croptimal and XwinSys, located in Israel. The Company’s board of directors is continuing to consider and evaluate strategic alternatives and is evaluating potential investment opportunities that will enhance the Company’s growth profile and future profitability.
TORONTO, April 24, 2018-- Eurocontrol Technics Group Inc., a Canadian public company specializing in the acquisition, development and commercialization of innovative test and measurement technologies for ...
TORONTO, Feb. 14, 2018 /CNW/ - Carpincho Capital Corp. ("Carpincho") announces that it has entered into a binding letter agreement (the "Letter Agreement") with MM Development Company, LLC (doing business as Planet 13 and Medizin), a privately held limited liability company existing under the laws of the State of Nevada ("MMDC"), which outlines the general terms and conditions pursuant to which Carpincho and MMDC have agreed to complete a transaction (the "Transaction") that will result in a reverse take-over of Carpincho by the current shareholders of MMDC. Founded in 2014, MMDC is a leading vertically integrated cannabis company in the State of Nevada.